Acara’s Top 10 Aesthetic Medical Predictions for 2010
Francis X. Acunzo, CEO and Founder of Acara, a leading US Aesthetic Medical Practice &
Medspa consulting firm provides his insight into what’s ahead in 2010 in the world of Aesthetic
Medicine and Medspas.
Branford, CT (Vocus) January 3, 2010 -- Francis X. Acunzo, CEO & Founder of Acara, a leading US Aesthetic
Medical Practice and Medspa consulting firm offers his vision into what to expect in 2010 in the world of
Aesthetic Medicine and Medical Spas.
1. Dysport will become a strong competitor to Botox. Dysport, Medicis’ new entry into the world of botulinum
toxin, was launched in the spring of 2009 and has begun to see increased demand as market awareness grows.
2. Non-invasive body contouring will continue to grow in popularity lead by Erchonia’s Zerona.
3. Face lifts will continue to drop in demand while liquid face-lifts grow in popularity, especially with the
younger market (40 -54 year olds)
4. Fat transfer, specifically for natural breast enhancement, will become sought after by women who were
previously uncomfortable with implants.
5. Laser Lipolysis will continue to be one of the most in-demand medical aesthetic procedures due to its
minimal downtime and great results.
6. The younger audience (24 – 40 year olds) will continue to discover aesthetic medical services for preventive
7. There will be an increase in the number of men having aesthetic medical procedures starting with facial
fillers and injectibles (i.e. Botox, Restylane, Radiesse, etc.)
8. The tipping point of when men and women want to have their tattoos removed will arrive and the demand
will grow exponentially.
9. Facial Rejuvenation will come of age as medical practitioners perfect their skill combining aesthetic medical
facial procedures for a complete Medical Makeover including the combination of fractional resurfacing, ablative
resurfacing, chemical peels, photofacials, skin tightening, injectibles and